These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 5535904)
1. Formulation for optimal safety and effectiveness. Schlichting DA Am J Pharm Sci Support Public Health; 1970; 142(1):16-22. PubMed ID: 5535904 [No Abstract] [Full Text] [Related]
3. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries]. Burow W; Lüllmann H Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578 [No Abstract] [Full Text] [Related]
4. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
5. A product standards form for new radipharmaceuticals. Warbick A Am J Hosp Pharm; 1974 Feb; 31(2):165-6. PubMed ID: 4815850 [No Abstract] [Full Text] [Related]
6. Influence of compounding on sterility and stability of drugs. Hardee GE J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582 [No Abstract] [Full Text] [Related]
7. Biological testing for safe O-T-C medications. Brogle RC Am J Pharm Sci Support Public Health; 1970; 142(1):23-8. PubMed ID: 4935890 [No Abstract] [Full Text] [Related]
8. Anticipated revisions to the current good manufacturing practice regulations. Mitchell CM Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938 [No Abstract] [Full Text] [Related]
9. Improving drug quality through certification experience. Weiss PJ Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related]
10. [Risks in the delivery of drugs from the point of manufacture to the patient. I. Risks in manufacturing and compounding]. Samková M; Solich J Cesk Farm; 1981 Dec; 30(10):349-54. PubMed ID: 7332939 [No Abstract] [Full Text] [Related]
12. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879 [No Abstract] [Full Text] [Related]
13. Drug identification. The problem in dental out-patients. Stephen KW; Laird WR Br Dent J; 1968 Jun; 124(11):521-5. PubMed ID: 5239909 [No Abstract] [Full Text] [Related]
14. Bacteriological purity--a consideration in the manufacture and packaging of pharmaceuticals. Brennan EC; Baker DE; Gasdia SD Am J Hosp Pharm; 1968 Jun; 25(6):302-4. PubMed ID: 4968569 [No Abstract] [Full Text] [Related]
15. Current perspectives on stability of protein drug products during formulation, fill and finish operations. Rathore N; Rajan RS Biotechnol Prog; 2008; 24(3):504-14. PubMed ID: 18484778 [TBL] [Abstract][Full Text] [Related]
17. [Various aspects of the significance of government control in drug supply]. Teijgeler CA; Samsom RJ Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999 [No Abstract] [Full Text] [Related]
18. Ergonomic and economic aspects of total parenteral nutrition. Genton L; Mühlebach S; Dupertuis YM; Pichard C Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):149-54. PubMed ID: 16477180 [TBL] [Abstract][Full Text] [Related]
19. [The trade-mark]. Kohlstaedt E Med Welt; 1969 Oct; 40():2209-11. PubMed ID: 5355668 [No Abstract] [Full Text] [Related]
20. Spurious and counterfeit drugs: a growing industry in the developing world. Gautam CS; Utreja A; Singal GL Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]